Baseline characteristics of 36 mepolizumab-patients. Experiences from the clinical practice

被引：1
|
作者：
Bjerrum, Anne Sofie
Skjold, Tina
Schmidt, Johannes
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷
关键词：
D O I：
10.1183/1393003.congress-2017.PA3588
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3588
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy of mepolizumab in usual clinical practice and characteristics of responders
    Rodriguez-Garcia, Carlota
    Blanco-Aparicio, Marina
    Jose Nieto-Fontarigo, Juan
    Blanco-Cid, Nagore
    Gonzalez-Fernandez, Coral
    Mosteiro-Anon, Mar
    Calvo-Alvarez, Uxio
    Perez-De-Llano, Luis
    Dolores Corbacho-Abelaira, Maria
    Lourido-Cebreiro, Tamara
    Miguel Dominguez-Juncal, Luis
    Crespo-Diz, Carlos
    Dacal-Quintas, Raquel
    Pallares-Sanmartin, Abel
    Dacal-Rivas, David
    Javier Gonzalez-Barcala, Francisco
    RESPIRATORY MEDICINE, 2021, 187
  • [2] BASELINE CHARACTERISTICS OF BULGARIAN PATIENTS PRESCRIBED EVOLOCUMAB IN CLINICAL PRACTICE
    Petkova, R.
    Postadzhiyan, A.
    Petrov, I.
    Tisheva, S.
    Borizanova-Petkova, A.
    Bridges, I.
    ATHEROSCLEROSIS, 2020, 315 : E212 - E212
  • [3] Baseline characteristics in stroke patients with atrial fibrillation: Clinical trials versus clinical practice
    Tanislav C.
    Milde S.
    Schwartzkopff S.
    Misselwitz B.
    Sieweke N.
    Kaps M.
    BMC Research Notes, 8 (1)
  • [4] y Baseline Characteristics in Patients with Eosinophilic Granulomatosis with Polyangiitis in the US Initiating Mepolizumab
    Silver, Jared
    Deb, Arijita
    Packnett, Elizabeth
    McMorrow, Donna
    Morrow, Cynthia
    Bogart, Michael
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 231 - 232
  • [5] Patients with severe eosinophilic asthma treated with Mepolizumab: Results from our clinical practice
    Hernandez-Martin, Irene
    Barranco, Pilar
    Sanchez-Jareno, Marta
    Palao-Ocharan, Paola
    Dominguez-Ortega, Javier
    Romero-Ribate, David
    Alberto Luna-Porta, Juan
    Quirce, Santiago
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB94 - AB94
  • [6] Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics
    Jayne, David R. W.
    Terrier, Benjamin
    Hellmich, Bernhard
    Khoury, Farieez
    Baylis, Lee
    Bentley, Jane H.
    Steinfeld, Jonathan
    Yancey, Steven W.
    Kwon, Namhee
    Wechsler, Michael E.
    Akuthota, Praveen
    ERJ OPEN RESEARCH, 2024, 10 (01)
  • [7] Comparing baseline characteristics of patients from routine clinical practice and those who enrolled in clinical trials. Information from the EuroHeart Failure Survey
    Lenzen, MJ
    Galvan, ED
    Reimer, WSO
    Boersma, E
    Follath, F
    Komajda, M
    Swedberg, K
    Cleland, J
    EUROPEAN HEART JOURNAL, 2003, 24 : 147 - 147
  • [8] Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice
    Richards, L. B.
    Van Bragt, J. J. M. H.
    Aarab, R.
    Sont, J. K.
    Weersink, E. J. M.
    Braunstahl, G. J.
    Ten Brinke, A.
    Bel, E. H. D.
    Maitland-Van der Zee, A. H.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [9] Characteristics of patients receiving mepolizumab in real-world practice - REALITI-A study
    Kwon, Namhee
    Gemzoe, Kim
    Worsley, Sally
    Gunsoy, Necdet
    Joksaite, Sandra
    Van Dyke, Melissa
    Bettinson, Carys
    Albers, Frank
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [10] Effectiveness of mepolizumab in patients with severe eosinophilic asthma: results from real-world clinical practice in Finland
    Koistinen, Ville
    Kauppi, Paula
    Idanpaan-Heikkila, Juhana
    Veijalainen, Lauri
    Iso-Mustajarvi, Ilona
    Ylisaukko-Oja, Tero
    Mehtala, Juha
    Viinanen, Arja
    Kilpelainen, Maritta
    JOURNAL OF ASTHMA, 2022, 59 (12) : 2375 - 2385
12345